Understanding Malignant Pleural Mesothelioma: A Closer Look at Genomic Patterns

ByHolly Zink
Understanding Malignant Pleural Mesothelioma: A Closer Look at Genomic Patterns

Scientists studied how asbestos exposure alters the genes of malignant pleural mesothelioma. They published their findings in the Journal of Environmental Pathology, Toxicology, and Oncology. This effort showed how the genes of three tumors form. Overall, the study deepened our knowledge of mesothelioma’s genetic changes and their connection to asbestos.

The Genetic Secrets of Mesothelioma

Cancer is a disease that can affect different parts of our bodies. One type of cancer that can develop in the lungs is called malignant pleural mesothelioma. This type of cancer is rare and can be caused by being around a material called asbestos.

Asbestos is a material that was used in buildings and factories in the past. When asbestos fibers are breathed in, they can harm the lining of the lungs and lead to malignant pleural mesothelioma. Malignant pleural mesothelioma is rare and linked to asbestos. So, we don’t know as much about its genes as we do about other common cancers.

In a recent study, scientists wanted to learn more about the genes in tumors. They focused on malignant pleural mesothelioma. They studied the genes of three malignant pleural mesothelioma tumors. They used special techniques to look at the entire genetic code.

Patterns in Mesothelioma Genomic Data

One important thing they found was changes in genes like BAP1, RB1, and TP53 in two of the patients. These genes are important in cancer development. These two patients also had lots of changes in how their chromosomes, the parts of our cells that carry genes, looked. This kind of chromosome change is rare and is called chromoanasynthesis.

The changes in the third patient’s chromosomes were simpler. But, they still affected key cancer genes like TGFBR1, KMT2C, and PALLD. This shows that while the chromosome changes may differ in mesothelioma tumors, the gene changes are similar.

The study also found some genes. For example, XRCC1 and ERCC2. These genes could be targeted with specific treatments. They also found a new gene fusion, SKA3-DDX10, in two of the tumors. This fusion has not been seen before in this cancer.

This study helps us understand more about the genes in mesothelioma tumors. It also shows how they might be treated. By learning more about the genetics of malignant pleural mesothelioma, scientists hope to find better ways to treat this rare cancer.

Source:

Tuncel, Tunç, Güntülü Ak, Hasan Veysi Güneş, and Muzaffer Metintaş. “Complex Genomic Rearrangement Patterns in Malignant Pleural Mesothelioma Due to Environmental Asbestos Exposure.” Journal of Environmental Pathology, Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 43, no. 2 (2024): 13–27. https://doi.org/10.1615/JEnvironPatholToxicolOncol.2023046200.

 

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    ByAlex Strauss

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…